Dr. Emerson Perin to be honored at 18th Annual Texas Update in Cardiovascular Advancements
Over the past decade, physicians and scientists have worked diligently to find ways to combat the various physiological and behavioral risk factors and the genetic alterations associated with cardiovascular disease.
The 18th Texas Update in Cardiovascular Advancements will be held February 9, 2019 and will honor this year’s 2019 Ray C. Fish Award for Scientific Achievement recipient, Emerson Perin, MD, PhD.
The Ray C. Fish Award for Scientific Achievement is presented at the award luncheon each year in The Ansary Atrium overlooking the heart of the Texas Medical Center. The Ray C. Fish Foundation helped make Texas Heart Institute a reality and was established by its founder so that others might be encouraged to broaden man’s self-knowledge and to keep the American dream alive. The award is Texas Heart Institute’s highest professional award given in honor of this extraordinary individual each year.
This annual tradition, now in its eighteenth year, is a one-day symposium filled with feature lectures and discussions by distinguished faculty who provide current information on the status and future directions of cardiovascular medicine and surgery.
The faculty highlight the most recent progress in the diagnosis and treatment of cardiovascular disease, as well as new and emerging therapeutic modalities.
- 2019 Ray C. Fish Lecture Cell Therapy for the Heart: A Journey to Approval: Emerson Perin, MD, PhD
- PCKS9 Inhibitors: Are They Alternatives to Treating Elevated LDLs in Patients Intolerant of Statins? | Vijay Nambi, MD, PhD
- Non-Invasive Imaging of Vascular Inflammation | Darren Woodside, PhD
- Latest Development in Treating Patients with TAVR | David Fish, MD
- Hormonal Therapy for Post Menopaused Women at High Risk of CAD: What is Best? | Stephanie Coulter, MD
- Closure Devices for Mitral Valve Regurgitation, ASDs, and VSDs:What Progress Has Been Made? | Guilherme Silva, MD
- Advances in Radiofrequency Ablation of Atrial Fibrillation |Abdi Rasekh, MD
- Treating Patients with CHF and LV Systolic Dysfunction by Treating Mitral Regurgitation | Andrew B. Civitello, MD
- Update on the Treatment of DVT | Zvonimir Krajcer, MD
- Treating CHF by Stimulating Cardiogenesis Directly | James F. Martin, MD, PhD
Learn More & Register Online
